Chewable B12 tablets begin absorbing through the oral mucosa before reaching the stomach, providing an absorption pathway that bypasses some of the reliance on intrinsic factor making the chewable format particularly well suited to those who may have compromised digestive absorption.*
A mere disclaimer that something is for research use only when the evidence suggests that the chemical isnt just being used for research would probably not be particularly persuasive from a legal standpoint, says Patti Zettler, an expert on food and drug law and the John W
Clinical Pathobiochemistry of Vitamin B12
Prolonged use of Vitamin B6 (over 2 months) at high doses exceeding 1g/day can lead to severe peripheral neuropathy, with symptoms including unsteady gait and numbness in the hands and feet
P140/Lupuzor reached Phase III clinical trials specifically for SLE, demonstrating that peptide-based approaches are being seriously investigated as therapeutic options
Selling and possessing these compounds for genuine laboratory research is broadly allowed, but marketing them for human use crosses a clear line
